Related Experiment Video
Updated: Feb 11, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes
Sascha Pilemann-Lyberg1,2, Tine Willum Hansen2, Frederik Persson2
1Medical Research Laboratory, Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
Insights
In type 1 diabetes, higher plasma uric acid (UA) correlates with reduced kidney function and increased diabetic complications. This link between elevated UA and lower estimated glomerular filtration rate (eGFR) and diastolic blood pressure (BP) persists independently of other risk factors.
Area of Science:
- Endocrinology
- Nephrology
- Cardiology
Background:
- Type 1 diabetes (T1D) management involves monitoring for complications.
- Plasma uric acid (UA) is a purine metabolite with potential roles in metabolic and cardiovascular health.
- The relationship between UA and diabetic complications in T1D requires further elucidation.
Purpose of the Study:
- To investigate the association between plasma uric acid levels and the presence of diabetic nephropathy and cardiovascular risk factors in patients with type 1 diabetes.
- To determine if these associations are independent of traditional risk factors.
Main Methods:
- Cross-sectional study of 676 Caucasian patients with type 1 diabetes.
- Comparison of participants with UA in the highest quartile versus the lowest three quartiles.
- Linear regression analyses, adjusted for age, sex, diabetes duration, BMI, lipids, smoking, HbA1c, BP, UAER, eGFR, and RAAS blockers.
Main Results:
- Higher UA was associated with lower eGFR, higher urinary albumin excretion rate (UAER), and increased pulse wave velocity in unadjusted analyses.
- Unadjusted analyses showed associations between higher UA and higher nighttime systolic BP and cardiovascular disease, but these did not remain significant after adjustment.
- UA levels were higher across different retinopathy groups and in patients with accelerated eGFR decline, though these associations lost significance after adjustment.
Conclusions:
- In type 1 diabetes, elevated plasma uric acid is linked to impaired kidney function and other diabetic complications.
- The association between higher UA and reduced eGFR and diastolic blood pressure is independent of established risk factors.
Background:
To examine the association between plasma uric acid (UA) and the presence of diabetic complications including diabetic nephropathy and cardiovascular risk factors in patients with type 1 diabetes.
Methods:
This study, which is cross-sectional in design, included 676 Caucasian type 1 diabetes patients from the Steno Diabetes Center Copenhagen. Participants with UA within the three lowest sex-specific quartiles were compared with participants with levels in the highest quartile. Unadjusted and adjusted linear regression analyses were applied. Adjustment included sex, age, diabetes duration, body mass index, high-density lipoprotein cholesterol, smoking, haemoglobin A1c, 24-h pulse pressure, urinary albumin excretion rate (UAER), estimated glomerular filtration rate (eGFR) and treatment with renin-angiotensin-aldosterone system blockers.
Results:
Of the 676 patients, 372 (55%) were male, mean ± SD age was 55 ± 13 years and eGFR was 82 ± 26 mL/min/1.73 m2. The median UA was 0.30 (interquartile range 0.23-0.37) mmol/L. UA in the upper sex-specific quartile was associated with lower eGFR, higher UAER and carotid-femoral pulse wave velocity and lower 24 h and daytime diastolic blood pressure (BP) in unadjusted analyses (P < 0.001). Moreover, UA in the upper sex-specific quartile was associated with higher nighttime systolic BP and the presence of cardiovascular disease in unadjusted analyses (P ≤ 0.01), but significance was lost after adjustment (P ≥ 0.17). UA was higher across the retinopathy groups [nil (n = 142), simplex (n = 277), proliferative (n = 229) and blind (n = 19)] in unadjusted analyses (P < 0.0001), but not after adjustment (P = 0.12). Patients with an accelerated decline in eGFR (≥3 mL/min/year) had significantly higher UA at baseline (P = 0.006) compared with slow decliners (<3 mL/min/year), but significance was lost after adjustment (P = 0.10).
Conclusions:
In type 1 diabetes patients, higher UA was associated with lower kidney function and other diabetic complications. The association between higher UA and lower eGFR and lower diastolic BP was independent of traditional risk factors.
More Related Videos
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer

